Personalized Medicine in the Clinical Management of Colorectal Cancer

Tsao-Wei D, Stoehlmacher J, Groshen S, Lenz Hj, Iobal S, Ghaderi, Park D, A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer. Anticancer Research. ,vol. 21, pp. 3075- 3079 ,(2001)

A Paradiso, G Simone, S Petroni, B Leone, C Vallejo, J Lacava, A Romero, M Machiavelli, M De Lena, C J Allegra, P G Johnston, Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients. British Journal of Cancer. ,vol. 82, pp. 560- 567 ,(2000) , 10.1054/BJOC.1999.0964

R. F. Bonner, CELL SAMPLING: Laser Capture Microdissection: Molecular Analysis of Tissue Science. ,vol. 278, pp. 1481- 1483 ,(1997) , 10.1126/SCIENCE.278.5342.1481

Robbert J. van Alphen, Alex Sparreboom, Kees Nooter, Ron H. J. Mathijssen, Walter J. Loos, Gerrit Stoter, Jaap Verweij, Clinical pharmacokinetics and metabolism of irinotecan (CPT-11) Clinical Cancer Research. ,vol. 7, pp. 2182- 2194 ,(2001)

C G Leichman, H J Lenz, L Leichman, K Danenberg, J Baranda, S Groshen, W Boswell, R Metzger, M Tan, P V Danenberg, Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. Journal of Clinical Oncology. ,vol. 15, pp. 3223- 3229 ,(1997) , 10.1200/JCO.1997.15.10.3223

A F Sobrero, C Aschele, J R Bertino, Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation. Journal of Clinical Oncology. ,vol. 15, pp. 368- 381 ,(1997) , 10.1200/JCO.1997.15.1.368

L Zoetekouw, H R Waterham, D J Richel, A B van Kuilenburg, F Baas, J Haasjes, R Meinsma, A H van Gennip, E W Muller, Lethal outcome of a patient with a complete dihydropyrimidine dehydrogenase (DPD) deficiency after administration of 5-fluorouracil: frequency of the common IVS14+1G>A mutation causing DPD deficiency. Clinical Cancer Research. ,vol. 7, pp. 1149- 1153 ,(2001)

P G Johnston, E R Fisher, H E Rockette, B Fisher, N Wolmark, J C Drake, B A Chabner, C J Allegra, The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. Journal of Clinical Oncology. ,vol. 12, pp. 2640- 2647 ,(1994) , 10.1200/JCO.1994.12.12.2640

B. Florentine, P. V. Danenberg, H.-J. Lenz, S. Groshen, K. D. Danenberg, P. G. Johnston, Linyun Zhou, C. G. Leichman, L. P. Leichman, Yi Ping Xiong, p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site. Clinical Cancer Research. ,vol. 4, pp. 1227- 1234 ,(1998)

D. Hollis, S. Sutherland, R. Goldberg, S. Alberts, A. Benson, J. Wade, R. Schilsky, R. Mayer, A. Venook, D. Niedzwiecki, Phase III study of irinotecan/5FU/LV (FOLFIRI) or oxaliplatin/5FU/LV (FOLFOX) ± cetuximab for patients (pts) with untreated metastatic adenocarcinoma of the colon or rectum (MCRC): CALGB 80203 preliminary results Journal of Clinical Oncology. ,vol. 24, pp. 3509- 3509 ,(2006) , 10.1200/JCO.2006.24.18_SUPPL.3509